Última revisión: 17 Ago 2021
Última actualización: 28 Sep 2018

Resumen

Diferenciales

Común

  • Fibroadenoma
  • Mama fibroquística
  • Esteatonecrosis
  • Papiloma intraductal
  • Absceso mamario
  • Hiperplasia ductal atípica (HDA) e hiperplasia lobular atípica (HLA)
  • Cáncer de mama invasivo
  • Carcinoma ductal in situ (CDIS)

Infrecuente

  • Tumor filoide
  • Adenoma
  • Cicatriz radial
  • Carcinoma lobular in situ (CLIS)

Colaboradores

Autores

Marios-Konstantinos Tasoulis, MD, PhD

General Surgeon

Fellow in Breast Surgery

Breast Surgery Unit

The Royal Marsden Hospital NHS Foundation Trust

London

UK

Divulgaciones

M-KT declares that he has no competing interests.

Agradecimientos

Dr Marios-Konstantinos Tasoulis would like to gratefully acknowledge Professor Anees Chagpar and Dr Matthew Bower, previous contributors to this topic. AC and MB declare that they have no competing interests.

Revisores por pares

William Dooley, MD, FACS

Director of Surgical Oncology

Department of Surgery

University of Oklahoma

G. Rainey Williams Chair in Surgical Breast Oncology

OU Breast Institute

Oklahoma City

OK

Divulgaciones

WD declares that he has no competing interests.

Jesus Solier Insuasty Enriquez, MD

Oncology Unit

Hospital Universitario Ramon Gonzalez Valencia

Bucaramanga

Colombia

Divulgaciones

JE declares that he has no competing interests.

Justin Stebbing, MA, MRCP, MRCPath, PhD

Consultant Medical Oncologist/Senior Lecturer

Department of Medical Oncology

Imperial College/Imperial Healthcare NHS Trust

Charing Cross Hospital

London

UK

Divulgaciones

JS declares that he has no competing interests.

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad